269 related articles for article (PubMed ID: 10598935)
1. Effects of tissue type plasminogen activator in embolic versus mechanical models of focal cerebral ischemia in rats.
Meng W; Wang X; Asahi M; Kano T; Asahi K; Ackerman RH; Lo EH
J Cereb Blood Flow Metab; 1999 Dec; 19(12):1316-21. PubMed ID: 10598935
[TBL] [Abstract][Full Text] [Related]
2. Reduction of tissue plasminogen activator-induced hemorrhage and brain injury by free radical spin trapping after embolic focal cerebral ischemia in rats.
Asahi M; Asahi K; Wang X; Lo EH
J Cereb Blood Flow Metab; 2000 Mar; 20(3):452-7. PubMed ID: 10724108
[TBL] [Abstract][Full Text] [Related]
3. Tissue plasminogen activator extravasated through the cerebral vessels: evaluation using a rat thromboembolic stroke model.
Harada T; Kano T; Katayama Y; Matsuzaki T; Tejima E; Koshinaga M
Thromb Haemost; 2005 Oct; 94(4):791-6. PubMed ID: 16270632
[TBL] [Abstract][Full Text] [Related]
4. Diffusion-, T2-, and perfusion-weighted nuclear magnetic resonance imaging of middle cerebral artery embolic stroke and recombinant tissue plasminogen activator intervention in the rat.
Jiang Q; Zhang RL; Zhang ZG; Ewing JR; Divine GW; Chopp M
J Cereb Blood Flow Metab; 1998 Jul; 18(7):758-67. PubMed ID: 9663506
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinase activation and blood-brain barrier breakdown following thrombolysis.
Kelly MA; Shuaib A; Todd KG
Exp Neurol; 2006 Jul; 200(1):38-49. PubMed ID: 16624294
[TBL] [Abstract][Full Text] [Related]
6. Antiactin-targeted immunoliposomes ameliorate tissue plasminogen activator-induced hemorrhage after focal embolic stroke.
Asahi M; Rammohan R; Sumii T; Wang X; Pauw RJ; Weissig V; Torchilin VP; Lo EH
J Cereb Blood Flow Metab; 2003 Aug; 23(8):895-9. PubMed ID: 12902833
[TBL] [Abstract][Full Text] [Related]
7. Polynitroxyl albumin reduces infarct size in transient focal cerebral ischemia in the rat: potential mechanisms studied by magnetic resonance imaging.
Beaulieu C; Busch E; Röther J; de Crespigny A; Hsia CJ; Moseley ME
J Cereb Blood Flow Metab; 1998 Sep; 18(9):1022-31. PubMed ID: 9740106
[TBL] [Abstract][Full Text] [Related]
8. Infarct reduction in rats following intraventricular administration of either tissue plasminogen activator (tPA) or its non-protease mutant S478A-tPA.
Yi JS; Kim YH; Koh JY
Exp Neurol; 2004 Oct; 189(2):354-60. PubMed ID: 15380485
[TBL] [Abstract][Full Text] [Related]
9. Long-term functional and neurological outcome after simultaneous treatment with tissue-plasminogen activator and hyperbaric oxygen in early phase of embolic stroke in rats.
Michalski D; Küppers-Tiedt L; Weise C; Laignel F; Härtig W; Raviolo M; Schneider D; Hobohm C
Brain Res; 2009 Dec; 1303():161-8. PubMed ID: 19766603
[TBL] [Abstract][Full Text] [Related]
10. A new rat model of thrombotic focal cerebral ischemia.
Zhang Z; Zhang RL; Jiang Q; Raman SB; Cantwell L; Chopp M
J Cereb Blood Flow Metab; 1997 Feb; 17(2):123-35. PubMed ID: 9040491
[TBL] [Abstract][Full Text] [Related]
11. Treatment of embolic stroke in rats with bortezomib and recombinant human tissue plasminogen activator.
Zhang L; Zhang ZG; Liu X; Hozeska A; Stagliano N; Riordan W; Lu M; Chopp M
Thromb Haemost; 2006 Jan; 95(1):166-73. PubMed ID: 16543976
[TBL] [Abstract][Full Text] [Related]
12. Treatment with melagatran alone or in combination with thrombolytic therapy reduced ischemic brain injury.
Wang CX; Ding X; Shuaib A
Exp Neurol; 2008 Sep; 213(1):171-5. PubMed ID: 18598697
[TBL] [Abstract][Full Text] [Related]
13. Effect of the duration of middle cerebral artery occlusion on the risk of hemorrhagic transformation after tissue plasminogen activator injection in rats.
Copin JC; Gasche Y
Brain Res; 2008 Dec; 1243():161-6. PubMed ID: 18835259
[TBL] [Abstract][Full Text] [Related]
14. Recombinant tissue plasminogen activator induces blood-brain barrier breakdown by a matrix metalloproteinase-9-independent pathway after transient focal cerebral ischemia in mouse.
Copin JC; Bengualid DJ; Da Silva RF; Kargiotis O; Schaller K; Gasche Y
Eur J Neurosci; 2011 Oct; 34(7):1085-92. PubMed ID: 21895804
[TBL] [Abstract][Full Text] [Related]
15. Normobaric hyperoxia and delayed tPA treatment in a rat embolic stroke model.
Henninger N; Bratane BT; Bastan B; Bouley J; Fisher M
J Cereb Blood Flow Metab; 2009 Jan; 29(1):119-29. PubMed ID: 18766195
[TBL] [Abstract][Full Text] [Related]
16. Long-lasting neuronal loss following experimental focal cerebral ischemia is not affected by combined administration of tissue plasminogen activator and hyperbaric oxygen.
Hobohm C; Laignel F; Kacza J; Küppers-Tiedt L; Heindl M; Schneider D; Grosche J; Härtig W; Michalski D
Brain Res; 2011 Oct; 1417():115-26. PubMed ID: 21914554
[TBL] [Abstract][Full Text] [Related]
17. Reperfusion after thrombolytic therapy of embolic stroke in the rat: magnetic resonance and biochemical imaging.
Busch E; Krüger K; Allegrini PR; Kerskens CM; Gyngell ML; Hoehn-Berlage M; Hossmann KA
J Cereb Blood Flow Metab; 1998 Apr; 18(4):407-18. PubMed ID: 9538906
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety profile of the carotenoid trans sodium crocetinate administered to rabbits following multiple infarct ischemic strokes: a combination therapy study with tissue plasminogen activator.
Lapchak PA
Brain Res; 2010 Jan; 1309():136-45. PubMed ID: 19891959
[TBL] [Abstract][Full Text] [Related]
19. Protective effects of statins involving both eNOS and tPA in focal cerebral ischemia.
Asahi M; Huang Z; Thomas S; Yoshimura S; Sumii T; Mori T; Qiu J; Amin-Hanjani S; Huang PL; Liao JK; Lo EH; Moskowitz MA
J Cereb Blood Flow Metab; 2005 Jun; 25(6):722-9. PubMed ID: 15716855
[TBL] [Abstract][Full Text] [Related]
20. Post-ischemic treatment of pentoxifylline reduces cortical not striatal infarct volume in transient model of focal cerebral ischemia in rat.
Vakili A; Zahedi khorasani M
Brain Res; 2007 May; 1144():186-91. PubMed ID: 17320054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
